Katrina Thornber, Author at European Medical Journal - Page 49 of 54

Optical Coherence Tomography for Stent Guidance Improves Outcomes in Complex PCI Cases: ESC 2024

ESC 2024: OCT-guided PCI in complex lesions reduced cardiac risks by 38% and spontaneous MI by 64% versus angiography, according to the OCCUPI trial.

Wearable ECG Device for Atrial Fibrillation Screening: ESC 2024

Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.

Could AI Diagnose Coronary Artery Disease? ESC 2024

The PROTEUS trial, presented at ESC 2024, evaluated the effectiveness of AI in standardizing clinician decision-making during stress echocardiography for coronary artery disease

Obesity Associated with Longer Survival in Immunotherapy-Treated Head, Neck Cancer

Obesity is linked to improved survival outcomes in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

COVID-19 Vaccine Does Not Increase Multiple Sclerosis Relapse Risk

A new study involving 124,545 MS patients reveals that COVID-19 vaccination does not significantly increase relapse risk, except in those with highly active, untreated MS.

Consciousness Detected in Unresponsive Patients

Recent research has revealed that brain scans can detect consciousness in some patients with severe brain injuries who appear unresponsive.

Liver Stiffness Identified as an Indicator of Hepatitis C Risk

Recent studies suggest liver stiffness as the primary indicator for assessing long-term risk after Hepatitis C virus treatment

Novel Non-invasive Model to Detect Varices in Hepatocellular Carcinoma

A new model combining clinical and imaging data effectively predicts the absence of high-risk varices in patients with unresectable hepatocellular carcinoma

Lecanemab Binds Amyloid Plaques in People with Down Syndrome

A new study reveals that an Alzheimer’s drug, binds effectively to amyloid plaques in people with Down syndrome but raises safety concerns due to its interaction with brain blood vessels.

Untreated Late-Life Hypertension Increases Alzheimer's Disease Risk

Recent research has shown that antihypertensive medications may reduce the risk of all-cause dementia by 13% and Alzheimer’s disease.